April 5, 2026 11:25 AM
India eyes boost in indigenous insulin production amid global supply concerns
India is looking to scale up domestic production of biosimilar insulin and diabetes care technologies as part of a broader push to strengthen its biomanufacturing capabilities, Union Minister Dr. Jitendra Singh said during a meeting with International Diabetes Federation (IDF) President-elect Dr. Niti Pall. The discussions focused on enhancing India’s capacity in insulin manufacturing, particularly biosimilar insulin, as well as expanding production of diabetes-related medical devices such as...


